PE/iFluor® 594 Anti-human CD101 Antibody *BB27*
The BB27 monoclonal antibody binds to human CD101, a 120 kD member of the Ig superfamily commonly found on the surface of T cells, granulocytes and dendritic cells. CD101 acts in important cellular pathways, for instance, the cell surface receptor signaling pathway. Additionally, in some organisms, it is an enhancer of myeloid leukocyte differentiation. From a research standpoint, it is of biological interest due to its association with key macromolecules/ligands. CD101 is a relatively rare antibody target, with fewer than 200 publications in the last decade. Even still, CD101 is often used in flow cytometry applications as a phenotypic marker for differentiation of cell types, especially in the study of immunology. This antibody was purified through affinity chromatography and conjugated to PE/iFluor® 594 (ex/em = 566/606 nm). It is compatible with the 561 nm laser and 585/29 nm bandpass filter (for example, as in the BD FACSJazz™).
Spectrum
Conjugation
We provide custom conjugation services for this antibody (eg. labeling of cd101 antibody with HRP). A list of available labels can be found in the table below:
For additional information about custom conjugations, please consult our services page here.
AF | AF350, AF488, AF555, AF594, AF647, AF680, AF700, AF750 |
Proteins | HRP, Alkaline Phosphatase, Streptavidin |
Tandems | APC, APC/Cy7, APC/AF750, APC/iFluor™ 700, APC/iFluor™ 750, PE, PE/Cy5, PE/Cy7, PE/AF610, PE/AF700, PE/iFluor™ 594, PE/iFluor™ 647, PE/iFluor™ 700, PE/iFluor™ 750, PE/Texas Red®, PerCP, PerCP/Cy5.5 |
Small Molecules | Biotin |
Traditional Dyes | FITC (fluorescein), TRITC, PacBlue, PacOrange, Cy3, Cy5 |
iFluor | 350, 405, 430, 450, 488, 514, 532, 546, 555, 560, 568, 594, 610, 633, 647, 660, 670, 680, 700, 710, 750, 790, 800, 810, 820, 840, 860, A7 |
mFluor | UV375, UV460, Violet 450, Violet 500, Violet 510, Violet 540, Blue 570, Green 620, Red 700, Red 780 |
For additional information about custom conjugations, please consult our services page here.
Page updated on April 25, 2025